Gossamer Bio, Inc.
- GOSS
- NASDAQ
- Biotechnology
- Pulmonary Hypertension Treatments
- Clinical-stage Biotech
- Rare Disease
$8.77
Today −1.35%Quote Oct 16, 2026, 08:00 PM UTC
−26.55%over the last month
Max drawdown −26.5%From 1-month high −26.5%3 months −22.3%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$4.29B
Quote Oct 16
Next earnings
Nov 4
Expected, not confirmed
Analyst target
$3.47
−60.4% from here
Floor
$8.68
1.1% below price
Where the price sits
18 analysts
Analyst range, low to high
$0.30$9.00
- Price $8.77
- Resistance $9.83
- Consensus $3.47
The price is just above its floor. Analysts' average target sits about 60% lower. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about GOSSPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
162
Founded
2015